Archive for category: HIV/AIDS

, ,

Sustained Funding & Combating HIV/AIDS in Comoros

HIV/AIDS in ComorosLimited health care infrastructure, economic vulnerability and heavy reliance on external humanitarian aid make the fight against HIV/AIDS in Comoros fragile. While HIV prevalence remains low, progress depends largely on donor-funded programs. Inconsistent and short-term funding threatens to reverse gains in prevention, treatment access and health system resilience. Sustained funding for HIV/AIDS in Comoros is essential to ensure long-term prevention, uninterrupted treatment and national health stability.

HIV/AIDS in Comoros: A Fragile Success

HIV prevalence in Comoros remains below 1%, one of the lowest rates in sub-Saharan Africa. This success is largely due to early prevention strategies, cultural factors and donor-supported health programs. However, limited domestic health financing means that HIV/AIDS services depend heavily on external support for antiretroviral treatment (ART), testing services and public awareness campaigns. Any reduction in funding risks service disruption, increased transmission and setbacks to national health goals. Donor-supported programs have included nationwide HIV awareness campaigns, voluntary counseling and testing services and integration of HIV services into primary health care, all of which have contributed to maintaining low prevalence levels. Here is why sustained funding matters.

Continuity of Treatment

HIV is a lifelong condition with no cure and requires continuous treatment with antiretroviral drugs to suppress the virus and protect the immune system. According to the World Health Organization (WHO), uninterrupted ART significantly reduces HIV-related deaths and prevents drug resistance. Funding interruptions can lead to medication shortages, treatment gaps and declining health outcomes. Sustained funding for HIV/AIDS in Comoros ensures consistent patient monitoring, reliable medication supply and effective long-term care.

In Comoros, antiretroviral treatments are largely financed internationally, particularly grants from the Global Fund. According to UNAIDS, this external supply creates challenges such as supply chain delays, limited laboratory capacity and difficulties to provide a consistent patient follow-up across the islands. Sustained funding for HIV/AIDS in Comoros ensures consistent patient monitoring, reliable medication supply and effective long-term care.

Prevention and Education

Prevention and education programs are critical to maintaining low HIV prevalence in Comoros. One major example is the national prevention of mother-to-child transmission (PMTCT) program, supported by international partners such as UNICEF and WHO, which provides testing, treatment and counseling to pregnant women living with HIV; as a result, HIV prevalence among pregnant women stands at an exceptionally low level and infants born to HIV-positive mothers have consistently tested HIV-negative under this initiative.

Existing initiatives include community-based awareness campaigns supported by UNAIDS and the Global Fund, HIV testing and counseling services and outreach programs targeting young people and women. International assistance has supplied critical testing equipment and strengthened health worker training, helping expand access to HIV information and services. These programs promote safe practices, reduce stigma and encourage early testing. Long-term funding allows these initiatives to operate consistently and expand into underserved communities, particularly in rural areas.

Strengthening Health Systems

Efforts are underway to broaden health system improvements in Comoros. Investments have supported clinic infrastructure, trained health care workers and strengthened disease surveillance systems. However, challenges remain, including shortages of medical staff, limited laboratory capacity and unequal access to care between urban and rural regions. These weaknesses increase vulnerability to HIV transmission and hinder treatment access.

In Comoros, HIV/AIDS-related investments have contributed to improved primary health facilities and health worker training, but the country continues to face shortages of medical personnel and limited diagnostic infrastructure, particularly outside urban areas. According to the World Bank, stronger health systems improve economic resilience and reduce poverty in developing countries.

Solution in Action: The Global Fund

Established in 2002, the Global Fund has played a key role in supporting HIV/AIDS programs in Comoros. The Global Fund is one of the main external financiers of HIV/AIDS programs in Comoros, supporting HIV treatment and prevention efforts in collaboration with national health authorities. By financing antiretroviral therapy, HIV testing and health system strengthening, the organization has expanded access to essential services.

According to the Global Fund, its investments support the delivery of HIV services across the country, demonstrating how sustained international funding strengthens national health capacity. In 2023, countries supported by the Global Fund reported that approximately 25 million people were on antiretroviral therapy, and 53.8 million HIV tests were conducted through its investments, reaching millions with prevention services. While these figures reflect global outcomes, they illustrate the scale of support provided to countries like Comoros.

Poverty and HIV/AIDS in Comoros

Poverty remains a significant challenge in Comoros, where a large portion of the population lives below the national poverty line. Using the international poverty line of $3.65 per day, about 39.5% of Comorians lived in poverty in 2023, reflecting persistent economic hardship that constrains access to essential services like health care, education and transportation. In Comoros, long distances to health facilities, high out-of-pocket costs for care and shortages of trained health workers make it difficult for poor households to obtain HIV testing and treatment services, contributing to health inequalities. People living in poverty are also more vulnerable to poor health outcomes due to malnutrition and limited medical access. Addressing HIV/AIDS through sustained funding helps reduce these inequalities and supports broader poverty reduction efforts.

The Role of International Support

International support remains vital to sustaining HIV/AIDS programs. Comoros participates in regional HIV response efforts coordinated by UNAIDS and partners, such as Indian Ocean Island forum meetings aimed at strengthening prevention and treatment planning, demonstrating the active role of international support in shaping the country’s HIV strategy. Donor countries and multilateral institutions help bridge funding gaps while the government gradually strengthens domestic health financing. Sustained funding aligns with global commitments to end AIDS as a public health threat by 2030 and ensures that small island developing states like Comoros are not left behind.

Conclusion

The fight against HIV/AIDS in Comoros is about securing long-term public health and economic stability. Sustained funding ensures uninterrupted treatment, effective prevention strategies and stronger health systems. Programs supported by the Global Fund and other international partners show that long-term investment expands access to ART, increases testing in rural communities and reduces health disparities. With predictable and sustained funding, Comoros can continue to maintain low HIV prevalence, improve health outcomes and support sustainable development.

– Numahaiseta Sillah Tunkara

Numahaiseta is based in Duisburg, Germany and focuses on Technology and Politics for The Borgen Project.

Photo: Flickr

, ,

The HIV Epidemic in Zambia: Project HOPE

HIV Epidemic in ZambiaAccording to the Centers for Disease Control and Prevention (CDC), in 2023, 9.8% of Zambia’s population ages 15 to 49 was living with HIV, with about 15,000 related deaths recorded that same year. Based on the distribution of HIV across the population, the United Nations Children’s Fund (UNICEF) classifies Zambia as having a generalized HIV epidemic. HIV epidemics are considered “generalized” when transmission occurs largely through sexual activity in the general population, meaning programs that focus only on specific vulnerable groups are unlikely to significantly reduce overall transmission or achieve eradication.

In Zambia, several nongovernmental organizations (NGOs) have worked to reduce the impact of the HIV epidemic. These include the Elizabeth Glaser Pediatric AIDS Foundation and FHI 360. One of these organizations was Project HOPE, a global health and humanitarian organization operating across five continents with a mission to improve access to care and health outcomes worldwide. Project HOPE has operated in Zambia since 2019, focusing on reducing the effects of the HIV epidemic, particularly among children and adolescents.

Project HOPE’s Efforts in Zambia

Because Zambia is experiencing a generalized epidemic, HIV transmission occurs primarily through unprotected sexual activity. However, there is a significant disparity between young men and women ages 15 to 24. In 2020, HIV prevalence among young women was 5.7%, compared with 1.8% among young men. This disparity may be linked to factors such as high rates of early pregnancy, earlier sexual debut, coercion linked to unequal power dynamics and age-disparate sexual relationships, all of which are prevalent among adolescent girls and young women in Zambia.

Project HOPE identified these dynamics as a major concern and focused its work on addressing the underlying socioeconomic factors that influence HIV transmission among adolescents and young adults.

On the ground, Project HOPE supported HIV treatment efforts by helping ensure access to pre-exposure prophylaxis (PrEP), counseling adolescents and young people on positive sexual health practices and supporting HIV health informatics programs. The organization also partnered with the Centre for Infectious Disease Research in Zambia to support the Empowered Children and Adolescents Project through community interventions and case management.

Through these efforts, Project HOPE provided antiretroviral therapy to 388,836 adults and children living with HIV and delivered gender-based violence education to 2,565 individuals. On Sept. 8, 2025, Project HOPE announced that it had ended operations in Zambia as of June 2025. The organization cited reductions in U.S. foreign assistance funding following a realignment of foreign aid policy as the primary reason for the decision.

The America First Global Health Strategy

The America First Global Health Strategy was introduced by the U.S. Department of State in September 2025. The strategy responded to concerns about inefficiencies in global health foreign assistance programs. According to the Department of State, only about 40% of global health aid reached frontline workers and commodities, while 60% supported technical assistance, program management and other overhead costs.

Officials attributed this imbalance to earlier policies that emphasized direct investment through NGOs, which they said created parallel supply chains and procurement systems alongside local governments.

As a result, the policy shift led to significant reductions in U.S. Agency for International Development funding for NGOs, with a greater emphasis on delivering aid through local governments. The stated goal is to strengthen public health systems and build long-term self-sufficiency in responding to crises such as the HIV epidemic.

The Role of NGOs in Zambia

As the America First Global Health Strategy takes shape, organizations such as Project HOPE have struggled to sustain operations in countries like Zambia. However, Steven Neri, Project HOPE’s senior regional director for Africa, emphasized the continued importance of NGOs when speaking with The Borgen Project.

“Project HOPE was able to bring our expertise from across Africa and around the world to support the HIV prevention, care and treatment program in Zambia,” Neri said. “Our ability to bring lessons from outside Zambia and work with Zambians to translate those lessons into effective HIV programs is something that I am proud of.”

Neri also highlighted the role of the President’s Emergency Plan for AIDS Relief (PEPFAR), which has invested more than $110 billion in HIV programs globally, in advancing innovation and expertise in HIV management.

The Future of HIV Management in Zambia

Although Project HOPE has concluded its operations in Zambia, HIV epidemic management continues through coordination between the U.S. and Zambian governments. On Nov. 18, 2025, the Department of State announced that the first doses of lenacapavir had been delivered to Zambia.

Lenacapavir is a twice-yearly injectable PrEP medication that offers a long-acting alternative to daily oral pills, particularly for individuals who face challenges with adherence or access to health care. On Nov. 4, 2025, after 12 working days of review, both tablet and injectable forms of lenacapavir received approval for HIV prevention from the Zambia Medicines Regulatory Authority.

As U.S. funding shifts away from NGOs and places greater responsibility on local governments, Project HOPE has emphasized the importance of retaining proven best practices during this transition. Neri expressed cautious optimism about the future of HIV management in Zambia while stressing the need for continued support for on-the-ground delivery.

“Making lenacapavir available in Zambia is consistent with the original focus of PEPFAR,” Neri said. “Without medicines, it is impossible to have a successful HIV program, and without program funding, it is hard to imagine how access to medicines will improve. The two go hand in hand.”

– Nikhil Kumar

Nikhil is based in Lexington, MA, USA and focuses on Global Health and Politics for The Borgen Project.

Photo: Flickr

, ,

Addressing HIV/AIDS in Malta

HIV/AIDS in MaltaMalta is a developed island located in the Mediterranean Sea, between Sicily and North Africa. With a relatively small population, 532,956 in 2023, according to the World Health Organization (WHO), the population still suffers from HIV/AIDS diagnoses. Despite these challenges, promising progress from NGO HIV Malta and the country’s effective health care facilities and expertise continue to steady the rate of positive infections. Here is information about HIV/AIDS in Malta.

What Are HIV and AIDS?

HIV, also known as human immunodeficiency virus, is a virus that results in illness from a weakened immune system. The virus attacks healthy cells in the body, ultimately exposing the body to other infections. People most commonly spread it through unprotected sex, contact with the body fluids of someone with HIV or even when sharing injection equipment.

Eventually, if people leave it untreated, it can lead to AIDS, which stands for Acquired Immunodeficiency Syndrome. AIDS is described as the last stage of HIV, where the body’s cells and immune system are severely damaged. It can eventually lead to death if people leave it untreated during the initial HIV stage.

The Times of Malta recorded Malta’s first case of AIDS in 1984. In 1986, an estimated 25 individuals had a positive HIV test, which triggered a national health response. The Health Education Unit published leaflets named Fatti dwar 1-AIDS, to warn people of the untreatable infection. Moving into the 2000s, positive HIV tests mounted to 210 in 2003. According to The Times of Malta, “HIV was then named a notifiable infection on January 27, 2004.”

According to the HIV Justice Network, Malta passed a disease transmission law in 2005, which made it a crime for someone with an HIV infection to recklessly or intentionally pass it on to another. The sentencing powers include life imprisonment, and monthly sentences or fines.

Poverty in Malta – HIV/AIDS Prevalence Amongst Migrant Groups 

While Malta’s economy continues to excel as a developed nation, poverty still affects the less fortunate, in this case, migrants fleeing their home to settle elsewhere. According to Trading Economics, Malta’s risk of poverty in 2024 reached 16.8%. Over the years, Malta has seen a fluctuating poverty rate, with both high and low peaks. Its highest recording reached 17.1% in 2019. The factors influencing poverty in Malta include variations in living conditions, unemployment rates and income inequality.

Across Malta, HIV/AIDS prevalence in migrants is more common than in nationals. To date, the country has welcomed 2,000 asylum seekers and 11,000 refugees, according to the World Health Organization (WHO). HIV testing is free for all individuals in Malta; however, if migrants receive a positive test, the treatment policy differs. Ultimately, those who do not have legal employment must pay for their treatment, resulting in higher untreated cases amongst migrants, due to high medical costs ranging between €600 to €1,500 monthly according to HIV Malta.

Background on HIV Malta 

HIV Malta is a non-governmental organization working to help focus on the well-being and necessary quality of life of those with HIV/AIDS in Malta. The NGO addresses HIV in Malta by implementing educational programs, prevention methods, advocacy groups and support services. Its main aims also include:

  • Relevant treatment and policy work should be carried out to improve the quality of life of those with HIV.
  • Educational campaigns that provide factual, knowledge-based information.
  • Making sure those with HIV can live their life with respect for their human rights.
  • Providing accurate information that is scientifically proven for testing and prevention. 
  • Working with stakeholders in the medical sector to perfect treatment. 
  • Working with the community and with other NGOs with strong, compatible objectives.

Key Accomplishments and Collaborations 

We Are Positive is an advocacy group that HIV Malta created in partnership with Checkpoint Malta and activist/artist Emma Grima. It aims to humanize HIV and promote sexual health in communities.

Its first artistic action, held in 2014 at the LOVE Monument in Spinola Bay, St Julian’s, included plastering the monument with 620 self-testing boxes and urging people to interact with them. The general public engaged in conversations, and people received encouragement to tell their HIV journey story. The box contained cards and stickers explaining where people could get tested. They highlighted the success of the campaign across their web page.

Checkpoint Malta also set up monthly peer support in 2024, encouraging those living with HIV to share their experiences in a confidential and safe space. Their ongoing monthly meetups provide an opportunity for people to communicate outside of medical settings.

The Future of HIV/AIDS in Malta 

With HIV Malta leading as a forefront NGO in providing expertise to reduce the spread and risk of HIV transmission across Malta, the country is looking at a promising decline in infections. According to the World Health Organization (WHO), the number of new HIV infections in Malta (per 1,000 uninfected population) has remained at 0.1 per 1,000 since the 1990s up until 2024. HIV/AIDS in Malta is showing promising progress with the availability of testing methods, prevention methods and treatment from expert clinics and hospitals. However, changes to treatment availability across the country, particularly for migrants, will help tackle the decline in positive infections.

– Zara Ashraf

Zara is based in London, UK and focuses on Good News and Global Health for The Borgen Project.

Photo: Unsplash

,

What Funding Cuts Mean for HIV/AIDS in Developing Countries

HIV/AIDS in developing countriesWorld AIDS Day was commemorated by the U.S. government on the first day of December every year since 1988 to honor those who have lost their lives to the disease, until this year. The White House made the decision this year not to commemorate World AIDS Day for the first time since the tradition was established, with promotion through official communication channels being prohibited for federal employees. This decision aligns with what UNAIDS has described as the most significant setback to the global HIV response in decades.

The organization attributes this decline to the 2025 funding crisis, driven by the White House’s cancellation of foreign aid for HIV/AIDS research and prevention, as well as the depletion of the President’s Emergency Plan for AIDS Relief (PEPFAR). PEPFAR is the U.S. government’s global HIV program established under President George W. Bush. The Guardian reports that PEPFAR is estimated to have prevented 25 million early HIV/AIDS-related deaths.

Nearly a year after the onset of the crisis, HIV/AIDS poses a greater threat to the global population than it has in recent years. The impact on HIV/AIDS in developing countries is especially severe, as they tend to rely most heavily on these resources.

A 75% Halt in Global HIV Funding

According to the UNAIDS’ 2025 World AIDS Day report, the U.S., the world’s largest economy, was the largest donor to the HIV/AIDS response, providing 75% of all international funding. This was until funding was halted earlier in the year, with other members of the international community, particularly European countries, caving to pressure from the White House to divert funding from foreign aid toward national defense spending, as reported by Reuters.

The report revealed that by the end of 2024, before the funding crisis began, the world was closer than ever to achieving SDG 3’s goal of eradicating AIDS worldwide by 2030. Of the 40.8 million people living with HIV, 31.6 million were receiving lifesaving treatment. Between 2010 and 2024, HIV prevention and treatment services contributed to a 40% decline in new infections and a 54% drop in AIDS-related deaths.

These improvements coincided with increases in funding during the same period, rising 28% domestically and 12% internationally. The 2025 UNAIDS Global AIDS Update reported that sub-Saharan Africa achieved a remarkable 56% decline in new HIV infections between 2010 and 2024. The report also highlighted that five countries, most of them in sub-Saharan Africa, are on track to reduce new infections by 90% by 2030 compared to 2010 levels.

HIV/AIDS in Developing Countries

According to the 2025 UNAIDS Global AIDS Update, by the end of 2024, external funding supported nearly 80% of HIV prevention programs in sub-Saharan Africa, 66% in the Caribbean and 60% in the Middle East and North Africa—making these regions particularly vulnerable amid the funding crisis. The report also noted that the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) had identified more than 60 countries at risk of losing assistance or having their grants reduced, including some that had recently been reclassified as upper-middle-income.

The 2025 UNAIDS World AIDS Day report notes that antiretroviral therapy programs are largely financed domestically outside of sub-Saharan Africa. However, they are particularly vulnerable to donor reductions in western and central Africa, where donors provide 90% of treatment-related funding—53% of which comes from the Global Fund. Some examples of how countries in these regions have been affected include:

  • The HIV prevention program in Eswatini lost 20% of its funding between 2024 and 2025, despite a 23% HIV prevalence among people aged 15 to 49.
  • The number of people using PrEP (prevention medication) fell by 64% in Burundi, 38% in Uganda and 21% in Vietnam.

What Needs To Change

Despite the challenges facing the global HIV response, UNAIDS executive Winnie Byanyima believes that AIDS can still be eliminated as a public health threat by 2030 through “urgency, unity and unwavering commitment.” The most impactful and simultaneously most challenging path forward is for the international community to help close the funding gap for HIV prevention. According to the 2025 UNAIDS Global AIDS Update, achieving global targets in low- and middle-income countries would require an annual investment of $21.9 billion.

The report also highlights a financial incentive for action, noting that “if the world embraces new technologies, efficiencies and approaches, the annual cost of the HIV response could fall by around $7 billion.” Furthermore, the report notes that community-led organizations have been central to the HIV response for more than 40 years, providing information and support, driving advocacy and conducting critical research. Their impact has been significant enough that multiple countries now permit them to deliver treatment services and receive funding from the Global Fund for community-led and civil society initiatives.

Additionally, the World Health Organization supports expanding access to lenacapavir, a six-monthly injection and a recent advancement in prevention medication, offering hope, despite ongoing funding challenges, in the fight against HIV/AIDS in Developing Countries.

– Luca Hanlon

Luca Hanlon is based in Brooklyn, NY, USA. and focuses on Good News, Politics for The Borgen Project.

Photo: Unsplash

,

HIV/AIDS in Tunisia

HIV/AIDS in TunisiaHIV/AIDS in Tunisia is still a challenge, but the country is making steady progress through better testing, treatment and community support. New data highlights the need for continued action to protect vulnerable groups and expand access to care.

Recent studies show that HIV/AIDS in Tunisia is shifting with new infections and AIDS-related deaths rising in recent years. In 2024, researchers estimated that 9,750 people were living with HIV in the country with more than 1,000 new cases recorded. Although national prevalence remains low, the epidemic is concentrated among key populations who face higher risks and significant barriers to care.

The Current Situation in Tunisia

Tunisia’s HIV epidemic remains relatively small, but recent data shows a worrying upward trend. In 2024, an estimated 9,750 people were living with HIV, and more than 1,030 new infections were reported. AIDS-related deaths also reached around 485 people, highlighting gaps in early detection and consistent treatment.

The epidemic is concentrated among key populations, including men who have sex with men, sex workers and people who inject drugs—groups that face high stigma and limited legal protection. According to UNDP, only about 20% of people living with HIV in Tunisia know their status and receive treatment, meaning many individuals remain undiagnosed and at risk of developing severe illness. Although overall national prevalence is still low at 0.1%, according to the World Bank, the increase in new infections shows that Tunisia needs stronger prevention, testing and community-based support systems.

Barriers and Challenges

Despite progress in health care, Tunisia still faces several challenges that make it difficult to control the HIV epidemic. One of the biggest issues is stigma and discrimination, especially toward key populations such as men who have sex with men, sex workers and people who inject drugs. UNDP reports that gaps in anti-discrimination laws leave these groups unprotected, making many afraid to seek testing or treatment.

Another major challenge is low testing and awareness. Only around 20% of people living with HIV know their status, which means thousands remain undiagnosed. Without early detection, individuals cannot begin treatment, increasing the risk of AIDS-related complications.

Poverty and Barriers To Accessing HIV Care

For many people living in poverty in Tunisia, getting consistent HIV care is still a major challenge, especially when transportation costs, lack of insurance and financial barriers limit access to clinics.

Treatment services are unevenly distributed across the country — most specialized HIV centers are located in Greater Tunis, Sousse, Monastir and Sfax — leaving the entire western region without coverage, which forces low-income patients to travel long distances they often cannot afford. Limited access contributes to poor treatment adherence, and Tunisia continues to fall behind global HIV goals, with only 32% of people living with HIV receiving antiretroviral therapy despite years of international commitments.

NGOs in Tunisia report increasing drug resistance and worsening health outcomes among patients who struggle to stay in care, underscoring the need for better support for vulnerable and poor communities.

Promising Efforts and Progress

Even with these challenges, Tunisia is taking important steps to strengthen its response to HIV. UNAIDS highlights the country’s leadership role in the region, noting its commitment to rights-based health policies and stronger engagement with young people.

Tunisian youth organizations have partnered with UNAIDS to push for better education, more inclusive services and meaningful participation in decision-making. UNDP is also supporting national efforts to update Tunisia’s HIV Strategic Plan, focusing on human rights, gender equality and better protection for key populations. This includes reviewing laws that limit access to services and working with local groups to improve outreach.

Broader health reforms are helping too. According to WHO and UNICEF, Tunisia is expanding community-based health programs and investing in stronger primary care. These reforms improve access to prevention, testing and counseling, especially for people in underserved areas. Together, these initiatives show that Tunisia is not only aware of the challenges, but actively working toward a more inclusive, accessible and sustainable HIV response.

Conclusion

HIV/AIDS in Tunisia continues to present real challenges, but ongoing reforms and community-led efforts show that progress is possible. With stronger prevention programs, better legal protection and wider access to testing and treatment, Tunisia can reduce new infections and support more people living with HIV. Continued collaboration between the government, NGOs and youth organizations will be essential to building a healthier and more inclusive future.

– Aila Alsakka

Aila is based in Nottingham, UK and focuses on Good News and Technology for The Borgen Project.

Photo: Wikimedia Commons

,

Improving the Response to HIV/AIDS in The Gambia

HIV/AIDS in GambiaThe Gambia implemented many initiatives, programs and policies to improve its HIV/AIDS response. The country is focusing its prevention efforts on key populations experiencing higher prevalence rates of HIV and improving the accessibility of treatment services to these populations. The integrated and comprehensive approach empowers girls and young women through secondary education, development of training for health care workers on prevention and treatments and specialized nutritional services for breastfeeding women with HIV/AIDS in the Gambia.

The Background 

The Republic of the Gambia experienced its first detection of HIV/AIDS in 1986. In response, they created a new department within the Ministry of Health called the National AIDS Control Programme (NACP). While the HIV/AIDS prevalence in the general population remains relatively low, at less than 2%, key subpopulations such as men who have sex with men (MSM) and female sex workers (FSW) experience disproportionately high prevalence rates. While the country continuously progresses in its treatment services for HIV/AIDS since 1986, progress stalled during the COVID-19 pandemic. Many resources, skills, personnel and medical equipment essential to HIV/AIDS treatment were repurposed during the pandemic to treat COVID-19 patients. In response to the dual HIV and COVID-19 epidemics, the Gambia improved its HIV/AIDS reduction strategies by investing in better prevention services, especially targeting key subpopulations and increasing the utilization and accessibility of treatment services.

 Key Statistics:

  • In 2020, more than half (55%) of the estimated 27,000 people living with HIV/AIDS in the Gambia were females aged 15 years and older.
  • In 2020, among people aged 15-24, three out of four new HIV infections were females.
  • In 2018, the HIV prevalence among FSW was more than 10%.
  • In 2018, the HIV prevalence among MSM was more than 35%.

National HIV/AIDS Policy 2022-2027

UNAIDS and the Gambia created a Joint Programme in 2022 to develop the National HIV/AIDS Policy 2022-2027. The policy advances the prevention and treatment of HIV/AIDS and diminishes societal and legal barriers limiting access to treatment services. The Joint Programme prioritizes the revision and implementation of stronger National HIV prevention policies and strategizing preventive measures targeting key populations to improve the response to HIV/AIDS in the Gambia.

Key Results: 

  • The Programme delivered a total of 100,000 HIV testing kits and more than 724,000 condoms for distribution into health care systems in 2022-2023.
  • On World AIDS Day in 2022, more than 110,000 Gambians accessed HIV testing and counseling services due to community outreach initiatives.
  • In 2022-2023, 122 professional health workers across the country shared best practices for improving access and quality of HIV services.

Education Plus Initiative

The Education Plus Initiative (2021-2025) is a preventative effort against HIV/AIDS specifically in girls and young women in sub-Saharan Africa. This joint Initiative includes UNAIDS, UNESCO, UNFPA, UNICEF and UN Women in response to the startling amount of young women and girls infected with HIV and dying from AIDS in sub-Saharan countries. The Gambia joined eight other countries in 2022 by launching the Education Plus Initiative. The initiative integrates expanded access to secondary education for adolescent girls as an entry point for comprehensive health education, HIV prevention strategies and women empowerment. 

Key Results: 

  • Completing secondary education contributes to a significant reduction in HIV among adolescent girls and young women, such as drops in new cases by one-third to one-half in some countries.

Prevention of Mother-to-Child Transmission Programme

The Gambia initiated the Prevention of Mother-to-Child Transmission Programme (PMTCT) in the early 2000s to prevent the transmission of HIV from HIV-positive mothers to their infants during pregnancy, childbirth and breastfeeding. The programme outlined several strategies and objectives to reduce mother-to-child transmission. Strategies to increase the utilization of services and testing included establishing Voluntary Confidential Counseling and Testing (VCCT) sites in health facilities, dissemination of information on the programme to the community and offering VCCT services to all women attending antenatal clinics. Strategies for effective treatment included providing antiretroviral (ARV) therapy to HIV-positive women, Cotrimoxazole to exposed children and counseling for infant feeding to HIV-positive mothers.

Key Results:

  • By 2009, 35% of facilities with antenatal, delivery and postnatal services offered PMCTC services.
  • By 2009, 51% of HIV-positive pregnant women completed a course of ARV prophylaxis.

HIV Training Services for Maternal and Health Facilities

With support from the Joint Programme, the Gambia improves the treatment of mothers and pregnant women with HIV and the prevention of vertical transmission. Training on providing comprehensive HIV services such as counseling, ARV treatment and infant feeding became accessible to health care workers working in maternal and health facilities. Advancements in HIV training for health workers is an important strategy to improve the response to HIV/AIDS in the Gambia.

 Key Results:

  • In 2022-2023, 115 HIV-positive mothers and pregnant women accessed HIV counseling and testing services.
  • In 2022-2023, 116 health care workers from five different regions completed training supported by the Joint Programme on improved early infant HIV diagnosis and delivery practices to prevent mother-to-child transmission.

Nutrition Education and Services for People Living With HIV

The Ministry of Health and the National Nutrition Agency in the Gambia collaborated to provide a three-month period of specialized nutritious food for breastfeeding women with HIV to optimize health status and outcomes. The National AIDS Control Programme (WFP) partnered with the Joint Programme to create a social and behavioral change communication training empowering community members to inform HIV-positive people on nutrition and breastfeeding with HIV. 

Key Results:

  • More than 3,000 pregnant and breastfeeding HIV-positive women in three regions received specialized nutritious food in order to improve health outcomes.
  • In 2022, 103 HIV-positive people attended community groups providing education on nutrition and health.

Poverty and HIV/AIDS 

Living in extreme poverty increases the risk of contracting HIV, and living with HIV/AIDS only exacerbates the burden of poverty. Basse is a region with one of the highest HIV/AIDS prevalence rates within the Gambia. The Basse region also has the highest rate of food insecurity, at 19%, in the country. Gender inequality and poverty make women in Africa especially vulnerable to infection due to lack of access to information, health care, formal education, financial opportunity and increased exposure to sexual violence. Furthermore, financial insecurity and violence against women lead to more FSW in impoverished communities. Indeed, FSW are a key population disproportionately affected by HIV/AIDS in the Gambia. 

Conclusion

The Gambia has taken various innovative measures to improve HIV/AIDS response. The focus on key subpopulations while developing prevention initiatives improved access to services and distribution of resources to those who need it most. Women and girls benefit from the integration of secondary education and HIV/AIDS information and enhanced nutritional services for breastfeeding women with HIV. The country used lessons learned from the halt in progress during the COVID-19 pandemic to reform and improve their reduction and prevention strategies to eliminate the HIV/AIDS epidemic.

– Sarah Merrill

Sarah is based in Matthews, NC,  USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Pixabay

, ,

The Progress of HIV/AIDS in Azerbaijan

HIV/AIDS in AzerbaijanHIV is a communicable disease that attacks the human immune system. It destroys CD4 cells, otherwise known as white blood cells. As time goes on, it weakens the immune system. As a result, it causes opportunistic infections such as fungal infections, tuberculosis and some cancers. Many patients do not feel symptoms of HIV for a few months after infection, and as a result, do not realize they have the disease. Compared to Europe, HIV/AIDS in Azerbaijan is comparatively low, but it is still a significant problem. The rate of new HIV infections increased by 0.09 per 1,000 uninfected people from 0.01 in 1990 to 0.1 in 2024.

Treatments for HIV/AIDS

Antiretroviral treatment (ART) prevents HIV transmission from mother to child through breastfeeding. Patients who use ART can also prevent HIV transmission to their sexual partners. However, patients must take ART every day for life. Moreover, reducing HIV transmission connects to harm reduction approaches, which specifically involves the provision of sterile injecting equipment. It proves that harm reduction services include not only needle and syringe programs but also the provision of opioid agonist treatment (OAT).

The Causes of HIV/AIDS in Azerbaijan

On August 3rd, 2016, there were 4,955 HIV-infected people in Azerbaijan; 73.2% of them were men while 26.8% were women. The most significant cause of HIV/AIDS in Azerbaijan was the use of drugs, accounting for 47% of cases. Meanwhile, the second-highest cause was heterosexual contact at 42.1% and the third-highest cause was unknown causes at 7.8%. Finally, the fourth-highest cause was homosexual acts at 1.8% and the fifth-highest cause was mother-to-child transmission, affecting 1.8%.

In Azerbaijan, HIV infection is a serious problem with many cases being connected to people who injected drugs. According to the official statistics of 2021, injection drug use caused 14% of new HIV infections in the country. Of 690 HIV infections, 97 people were people who injected drugs (PWID).

Treating HIV/AIDS in Azerbaijan

Of the 26,894 people in prison in Azerbaijan, 7,979 people were in prison because of illegal drugs on January 31st, 2023. In prison, HIV prevalence was 1.7% in 2020. ART has been available in prisons resulting in 91.8% prisoners receiving treatment in 2019. However, NSP and opioid substitution therapy (OST) were not accessible.

Access to treatment can be challenging for people in Azerbaijan. For example, the needle/syringe program (NSP) covered only 33.9% for each client, providing 55 needles and the unit cost was approximately €33. Meanwhile, OAT coverage was about 1% in 2024 and the price of it was about €133 per client in a year. However, the unemployment benefit proxy was just €1,245. In prison, imprisonment costs about €3,008 per person per year. A simple community package including NSP and OAT and the unemployment benefit were about €1,411 per person per year.

Women’s Challenges and Barriers to Health Care

According to a Eurasian Women’s Network on AIDS study in 2022, Azerbaijan’s National HIV Program did not particularly support women. The overall plan did not include information on addressing stigma, discrimination and human rights for women experiencing HIV, working as sex workers or using drugs.

Additionally, as the Republican AIDS Center mentioned in May 2025, 10,324 respondents living with HIV/AIDS in Azerbaijan mentioned that they faced stigma and barriers to accessing health care and testing services. According to HIV/AIDS patients, access to stigma-free, confidential testing and treatment services need to be a priority for Azerbaijan’s public health strategy in addition to addressing discrimination.

Progress Addressing HIV/AIDS in Azerbaijan

For the voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare in late 2020, Azerbaijan was able to access dolutegravir (DTG) based on the regimens in upper-middle-income countries, which included Azerbaijan, Belarus and Kazakhstan. In addition, ViiV Healthcare and MPP developed the first-of-its-kind agreement to increase access and affordability to DTG-based HIV treatment plans. As a result, Azerbaijan was able to reduce the price by more than 90% through efforts of communities, procurement agencies and others. The government of Azerbaijan began the actions concerning the import of specific syringes to prevent HIV/AIDS in Azerbaijan.

In 2025, the Ministry of Health mentioned that it will allocate $431,000 for the procurement of these specific syringes. As a component of the “Harm Reduction” project, the government will buy the syringes with a “low dead space.” They expect that these syringes will help prevent HIV.

The Azerbaijan Parliament adopted a new law on HIV/AIDS. It concentrated on human rights and the universal accessibility of HIV-related services, including services targeted at drug users who are both in and out of prison. With the support of United Nations Office on Drugs and Crime (UNODC) and national experts, it could develop these recommendations.

As mentioned by Ali Hassanov, Deputy Prime Minister of the Republic of Azerbaijan, National legislation and policy had to consider the interests and needs of people who injected drugs and prisoners. He also mentioned that efforts to address the social and economic risk factors for HIV infection were an important part of an efficient strategy to reducing the spread of HIV in the years to come. The social and economic factors meant that they deprived individuals of the power to protect themselves against HIV infection.

In addition, Hadi Rajabli, Chair of the Social Policy Committee mentioned that the new law included the prohibition of discrimination and stigmatization. It contained programs to prevent the contraction of HIV among at-risk groups and prison inmates.

Looking Ahead

The issue of HIV/AIDS in Azerbaijan is still challenging. However, Azerbaijan’s efforts have helped reduce the price of treatments by 90% and it expects that HIV prevention plans will improve. Furthermore, the parliament accepted a new law on HIV/AIDS with the aid of UNODC and national experts.

– Yunjae Lee

Yunjae is based in Vancouver, Canada and focuses on Global Health and Politics for The Borgen Project.

Photo: Unsplash

, ,

Addressing Syphilis, Hepatitis B and HIV/AIDS in the Maldives

HIV/AIDS in MaldivesIn October 2025, the World Health Organization (WHO) officially declared that the Maldives had become the first country in the world to accomplish ‘triple elimination’ of mother-to-child transmission of HIV, syphilis and hepatitis B. As a nation, the Maldives has demonstrated a dedication to targeted, all-encompassing health care, providing a blueprint for the rest of the world to follow in its footsteps towards a collective aim of eliminating preventable disease transmission. This milestone holds the promise of a protected generation born free of infection, making it more than just a medical triumph. The reduction of HIV/AIDS in the Maldives serves as a reminder worldwide that even smaller nations can spearhead global change with the right commitment and focus.

The Meaning of Triple Elimination

Essentially, in global health terms, “triple elimination” marks one of the highest standards a country can achieve: a victory against three life-threatening diseases. It represents an implication that mothers are no longer infecting their offspring with hepatitis B, syphilis or HIV, three diseases that took the lives of countless newborns. Although the diseases have not completely perished, their transmission has dropped to the point that they are no longer a concern to public health. Although these infections still exist, transmission rates fall below strict WHO thresholds. To receive recognition, a country must:

  • Test and treat nearly all pregnant women
  • Provide prompt newborn interventions, including the hepatitis B birth dose within 24 hours
  • Maintain consistent outcomes over several years

Triple elimination fundamentally demonstrates what can be achieved when governmental, medical and scientific efforts come together to provide every baby with an optimal start in life.

Mother-To-Child Transmission on the World Stage

Globally, an estimated 1.3 million women and girls living with HIV become pregnant each year. Congenital syphilis is the second leading cause of preventable stillbirth globally, preceded only by malaria. Hepatitis B, on the other hand, is a liver-attacking virus that can infect a newborn and cause chronic illness in later life. However, early detection, treatment and prompt vaccination—especially the hepatitis B birth dose within 24 hours of delivery—can prevent these diseases.

According to UNICEF, new HIV infections among children under five dropped by 62% between 2010 and 2024. However, to meet the 2030 goals that UNAIDS and its partners established as part of the UNAIDS Global Strategy to End AIDS, progress needs to be made at a much faster rate. To eradicate new infections in children and cut the number of HIV-related deaths among expectant mothers in half, treatment for all pregnant and nursing women living with HIV must be accelerated.

Where Poverty Fits In

Poverty increases vulnerability to mother-to-child transmission because families with low income often face:

  • Limited access to antenatal care
  • Delayed or missed screening
  • Higher rates of untreated infection
  • Less access to protection during intercourse
  • Difficulty affording transport or follow-up appointments

The Elimination of Mother-To-Child Transmission (EMTCT) Initiative

To assist nations in achieving these objectives, the World Health Organization (WHO) developed the Elimination of Mother-to-Child Transmission (EMTCT) initiative. Numerous countries have made strides with some succeeding in ‘dual elimination’ status for syphilis and HIV. However, no nation had ever successfully eliminated all three at the same time until the HIV/AIDS in the Maldives confirmation this year.

This makes EMTCT efforts essential for reducing inequality across countries, especially in regions with limited health care infrastructure. The Maldives became an active participant in the WHO South-East Asia Regional EMTCT Initiative in 2016. In 2018, due to the regulation provided by the EMTCT initiative, they implemented the ‘Agenda for Integrated Service Delivery’ and started a systematic data collection for HIV, syphilis and hepatitis B. The progress seen with HIV/AIDS in the Maldives highlights how strong public health systems can help overcome poverty-related barriers. 

In the Maldives, poverty and geographic isolation have historically increased the risk of mother-to-child transmission of infections like HIV, syphilis and hepatitis B. Dr Catharina Boehme, Officer-in-Charge at the WHO South-East Asia Regional Office, affirmed the significance of “equitable care across its dispersed islands.” The nation’s numerous outer islands have historically had lower income levels, fewer job prospects, and less access to social services than the capital region. Families in these islands were more likely to miss early screening or timely newborn vaccination due to reduced household income and inadequate health infrastructure, underscoring the connection between health risk and economic disadvantage. Acknowledging these disparities, the government structured its maternal health system on universal access: all islands now offer free testing, treatment and birth-dose vaccination, and the WHO’s EMTCT framework supports this model.

Maldive’s Methods

  1. Early and Universal Screening: By the mid-2010s, the Maldives integrated first-trimester HIV, syphilis and hepatitis B screening into routine antenatal care, ensuring that even women in remote islands received early diagnosis.
  2. High Antenatal Care Coverage: The government invested heavily in island-level health posts and trained midwives, increasing antenatal care coverage and reducing disparities between wealthier households and families experiencing poverty.
  3. Strong Vaccination Systems: The Maldives maintained hepatitis B birth-dose coverage above 95%, a key requirement for EMTCT validation. Skilled birth attendants on smaller islands received training to guarantee newborn vaccination within 24 hours.
  4. Free Access to Treatment: All testing and treatment for HIV, syphilis and hepatitis B were free of charge, removing financial barriers that typically disproportionately affect low-income families.
  5. Data-Driven Monitoring: Through support from the EMTCT initiative, the Maldives strengthened its data systems, enabling accurate tracking of infections, treatment uptake and birth outcomes.

Looking Ahead

Proving itself a leading agent in maternal and antenatal care, “The Maldives’ triple elimination stands as a powerful example of how sustained investment in health systems, innovation and community-based care can change the trajectory of public health,” said Ms. Payden, WHO Representative to the Maldives. The HIV/AIDS in the Maldives’ progress began more than a decade ago, long before triple elimination was in sight. Because its population is dispersed across more than 1,000 islands, the government prioritized a decentralized, community-based health care system to ensure equal access regardless of income or geography. As stated in the WHO’s South-East Asia update, the Maldives’ feat is credited to long-term, systemic investments that have sustained high antenatal care coverage and integrated first-trimester screening for all three infections across scattered island communities. For the children of the Maldives, the future now begins infection-free.

– Prubleen Bhogal

Prubleen is based in London, UK and focuses on Good News and Politics for The Borgen Project.

Photo: Pexels

, ,

Everything To Know About HIV/AIDS in Bolivia

HIV/AIDS in BoliviaHIV/AIDS in Bolivia affects less than 1% of the population. The U.S. Agency for National Development reports that this puts the country at the lowest in HIV prevalence within Latin America and the Caribbean region. Officials reported the first diagnosis of HIV in 1985. Although HIV prevalence has remained low, it disproportionately affects marginalized populations. Two populations that are disproportionately affected are men who have sex with other men (MSM) and transgender women. Societal stigma and prejudice against these groups have resulted, necessitating a response that addresses these specific issues. According to UNAIDS, infection rates have steadily declined since 1993 and reached about 0.16 per 1,000 people as of 2024. Death rates have also steadily declined since 2011. As of 2024, the death rate is about 0.04 per 1,000 people.

Background on HIV/AIDS

According to the World Health Organization (WHO), HIV is a virus that targets the immune system by attacking white blood cells. Bodily fluids from an infected person can spread HIV. This can include blood, breast milk, semen and vaginal fluids. Antiretroviral therapy treats HIV. Without treatment, HIV can develop into AIDS.

The Response

The United Nations developed UNAIDS, the Joint Programme on HIV/AIDS, to lead the global effort to eradicate it. UNAIDS’ main focus is to advocate for affected communities, provide technical support, collect data on the illness and assist countries that are most affected. The joint program in Bolivia has carried out various efforts to address HIV through prevention, testing and treatment. Community-based programs, supported by the Joint Programme, have provided access to HIV prevention packages in 2023 to MSM and transgender women. Furthermore, the Triple X (Xpressa, eXplora and eXige) campaign has run a social media initiative aimed at increasing condom usage. It has reached 111,000 young people and resulted in a 12% increase in condom distribution within the public health system in one year. Additionally, the government has developed national guidelines for pre-exposure prophylaxis with support from the World Health Organization (WHO) following its adoption of the preventive drug regimen.

Impacts of People in Poverty With HIV

People who live with HIV/AIDS in Bolivia face conditions conducive to poverty, such as food insecurity and unstable livelihoods face major obstacles in managing their treatment, indicating a connection between economic struggle and HIV-related health outcomes, according to a study performed by Palar and a team. The Pan American Health Organization (PAHO) states that more than a third of Bolivia’s population lived below the national poverty line in 2021, indicating economic strain that reflects the hardships patients described in the study.

Palar’s team determined that time conflicts with their jobs prevented many participants from getting their doses, the stigma of HIV caused the loss of jobs and that many HIV patients struggled to balance their treatments with expectations from informal or unpredictable employment. The study observes that these conditions directly impact antiretroviral adherence, especially for those who lack a stable income or consistent access to food. The team also notes that a food-assistance pilot program has helped ease these pressures through improving patients’ nutritional stability. This has helped patients take their medication correctly.

Addressing Disparities and Prejudices

Fighting HIV/AIDS in Bolivia importantly involves addressing the disparities within the populations it affects and the prejudices surrounding the disease. Capacity-building training and catalytic funding have supported civil society organizations in Bolivia to strengthen the HIV response, address stigma and discrimination and protect human rights. As UNAIDS reported, the Bolivian Network of People Living with HIV and the Ministry of Health have introduced a pulsometer, a pilot stigma and discrimination self-assessment tool, to gather data on stigma and discrimination directed toward people living with HIV and key populations within the healthcare system. This aims to address barriers to accessing services.

In 2022, officials created an essential care standard for vulnerable communities and integrated it across 3,000 health facilities. As UNAIDS outlined, this protocol includes guidelines that prevent stigma, ensure adherence to care and diagnosis standards for HIV and promote condom use. In an effort to decriminalize HIV transmission, REDBOL and the community-centered organization Asociación Un Nuevo Camino have created a project to modify the 2008 HIV law. Advocates organized social dialogues to pressure Congress.

Looking Ahead

Although HIV is not an epidemic among the general population in Bolivia, it is prevalent within concentrated communities. The government and external organizations have made consistent efforts to address and treat this disease. HIV carries significant societal stigma and prejudice; as such, the response has acknowledged discrimination against marginalized groups. The response has addressed the disease itself and has also worked to undo prejudice and discrimination toward marginalized communities.

– Sasha Banaei

Sasha is based in San Diego, CA, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Behind The Numbers: The Story of HIV/AIDS in Niger

HIV/AIDS in NigerNiger has one of the lowest HIV rates in sub-Saharan Africa – but experts warn that low prevalence does not mean low risk. Behind the calm statistics lies a fragile health system, deep gender disparities and poverty that magnifies every infection.

According to the Joint United Nations Program on HIV/AIDS (UNAIDS), as of 2020, about 31,000 people in Niger live with HIV, with roughly 1,200 new infections each year. While Index Mundi cites adult prevalence remaining steady at just 0.2% as of the same period, only 68% of those infected were on antiretroviral therapy (ART), leaving nearly a third untreated. In a country where more than 40% of citizens live in extreme poverty, these gaps carry steep social and economic costs.

A Hidden Epidemic

Health officials warn that Niger’s low HIV rate masks deeper weaknesses in detection and prevention. In an interview with the University Research Co, a company focused on international development and health, Halima Mainassara, Chief of Party for the U.S. Department of Defense HIV/AIDS Prevention Program (DHAPP) in Niger, reinforced the urgency of the disease, “Every new HIV case detected is important – their contacts also need to be tested,” says Mainassara, “This ensures that all individuals who test positive will receive treatment and that the virus cannot spread further.”

Despite gains – such as the integration of HIV and tuberculosis care in 262 treatment centers – resource shortages, long travel distances and stigma over HIV/AIDS in Niger still limit testing and follow-up, according to the World Health Organization – Africa (WHO AFRO). Per the same report, mortality among TB/HIV co-infected patients fell from 21% in 2019 to 14% in 2022, but coverage remains uneven between cities and rural areas.

Gender and Youth at the Margins

Women and young girls carry most of the burden. UNAIDS data from 2021 shows they account for just under 55% of HIV cases in Niger, reflecting social inequalities that restrict education, health care access and decision-making. Early marriage, gender-based violence and limited reproductive services heighten vulnerability.

“When a woman is divorced as a result of her HIV status, it is difficult for her to keep her children,” said Sona Soumaré Conté, President of an NGO working with HIV-positive women in Niger. “Their husbands are afraid their children will not be well taken care of or will become contaminated.”

A report by the Journal of the American Medical Association (JAMA) stated that adolescents are also at risk. Knowledge about HIV prevention among young people remains low, and misconceptions persist, especially in rural communities where sexual health education is scarce.

Poverty and the Global Connection

HIV and poverty form a vicious cycle. Illness limits productivity, weakens households and deepens food insecurity. A report that UNAIDS and the World Food Programme (WFP) did in 2022 found that for families already surviving on less than $2 a day, one untreated infection can mean lost income and school dropouts.

The link extends beyond Niger. Global efforts to end extreme poverty rely on stable, healthy populations. In the same report, the World Food Programme and UNAIDS launched a joint cash-transfer project that provides small stipends (≈ US $76 per quarter) to people living with HIV to improve treatment adherence, underscoring the inseparable link between health and development.

Solutions in Action

One organization leading change is Solthis, an international Non-Governmental Organization (NGO) partnering with Niger’s Ministry of Health to strengthen HIV prevention and care. Through its Lahiyata project launched in 2023, Solthis works in Maradi and Niamey to improve sexual and reproductive health among adolescent girls, offering education, counseling and access to HIV and STI testing. In addition, Solthis technical support program helped train health workers, upgrade laboratories and expand treatment access nationwide. According to data from UNAIDS, between 2022 and 2023, more than one million pregnant women in Niger received voluntary HIV counseling and testing, linking many to lifesaving antiretroviral therapy.

Progress and the Path Ahead

Niger’s progress is real: ART coverage has grown from 26% in 2011 to 68% in 2020, likely attributed to the increase of foreign aid between 2015 and 2020 and Niger’s adoption of UNAIDS’ “90-90-90” prevention framework, and nationwide awareness campaigns are improving testing uptake. But sustainability is fragile. Most funding comes from international donors, and local programs risk collapsing if aid declines, per UNAIDS. To secure its future, Niger must expand ART coverage for HIV/AIDS in Niger, target key populations, and confront stigma through education and inclusion.

– Matt Irwin

Matt is based in Brooklyn, NY, USA and focuses on Global Health for The Borgen Project.

Photo: Wikimedia Commons